Patents by Inventor Howard Jones

Howard Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7991801
    Abstract: A dynamic and synchronized real-time captioning system and method for streaming media. A streaming encoder module can provide a code injection to marry textual data and audio/video (AV) data in order to form a text and/or audio stream. A streaming control module can allow an end-user to specify font format utilized to embed into an AV stream. A delay enhancement tool can be adapted to adjust speed of the text and/or audio stream, which allows the end-user to receive the text and/or audio stream at a proper speed. A customized graphical user interface (CGUI) can be adapted to assist with streaming administration to provide an encoding option, caption source location, delay control and slide control. Therefore, the captioning system can be able to synchronize and deliver the textual data and the AV data for live media streaming at an end-user's system.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: August 2, 2011
    Assignee: International Business Machines Corporation
    Inventors: Danny Yen-Fu Chen, Troy Frank Burkman, Jesse Tijnagel, David Charles Howard-Jones, Brian R. Heasman
  • Patent number: 7968536
    Abstract: The present invention provides compounds useful as inhibitors of protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: June 28, 2011
    Assignees: Millennium Pharmaceuticals, Inc., Sunesis Pharmaceuticals, Inc.
    Inventors: Jennifer Cossrow, Bing Guan, Alexey Ishchenko, John Howard Jones, Gnanasambandam Kumaravel, Alexey Lugovskoy, Hairuo Peng, Noel Powell, Brian C. Raimundo, Hiroko Tanaka, Jeffrey Vessels, Thomas Wynn, Zhili Xin
  • Publication number: 20100324039
    Abstract: Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.
    Type: Application
    Filed: August 30, 2010
    Publication date: December 23, 2010
    Inventors: Michael Jones, David Gunn, John Howard Jones, Michael Van Zandt
  • Publication number: 20100158933
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Application
    Filed: December 9, 2009
    Publication date: June 24, 2010
    Applicant: PFIZER VACCINES LLC
    Inventors: ALAN DANIEL BROWN, BRIAN ROBERT CHAMPION, CLARE CHRISTY, DAVID PAUL GERVAIS, LYN HOWARD JONES, ANNE MARIA KRISTINA KJERRSTROM, DAVID CAMERON PRYDE, LEE RICHARD ROBERTS, DAVID MICHAEL WYATT
  • Publication number: 20100137301
    Abstract: Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.
    Type: Application
    Filed: February 8, 2010
    Publication date: June 3, 2010
    Inventors: Michael Lee Jones, David Gunn, John Howard Jones, Michael C. Van Zandt
  • Publication number: 20100010040
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: July 1, 2009
    Publication date: January 14, 2010
    Inventors: Lyn Howard Jones, Dannielle Frances Roberts, Ross Sinclair Strang
  • Publication number: 20090307267
    Abstract: A dynamic and synchronized real-time captioning system and method for streaming media. A streaming encoder module can provide a code injection to marry textual data and audio/video (AV) data in order to form a text and/or audio stream. A streaming control module can allow an end-user to specify font format utilized to embed into an AV stream. A delay enhancement tool can be adapted to adjust speed of the text and/or audio stream, which allows the end-user to receive the text and/or audio stream at a proper speed. A customized graphical user interface (CGUI) can be adapted to assist with streaming administration to provide an encoding option, caption source location, delay control and slide control. Therefore, the captioning system can be able to synchronize and deliver the textual data and the AV data for live media streaming at an end-user's system.
    Type: Application
    Filed: June 10, 2008
    Publication date: December 10, 2009
    Inventors: Danny Yen-Fu Chen, Troy Frank Burkman, Jesse Tijnagel, David Charles Howard-Jones, Brian R. Heasman
  • Patent number: 7612084
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: November 3, 2009
    Assignee: Pfizer Inc
    Inventors: Kim James, Lyn Howard Jones, David Anthony Price
  • Publication number: 20090264425
    Abstract: This invention relates to biaryl ether derivatives of formula (I) wherein R1, R3, R4, X, W, Y and m are defined in the description, and to compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof.
    Type: Application
    Filed: December 12, 2005
    Publication date: October 22, 2009
    Inventors: Lyn Howard Jones, Donald Stuart Middleton, Charles Eric Mowbray, Sandra Dora Newman, David Howard Williams
  • Publication number: 20090253739
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: June 10, 2009
    Publication date: October 8, 2009
    Inventors: Kim James, Lyn Howard Jones, David Anthony Price
  • Publication number: 20090215712
    Abstract: This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereofs, wherein R1 to R4 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodeficiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).
    Type: Application
    Filed: August 25, 2008
    Publication date: August 27, 2009
    Inventors: Lyn Howard JONES, Charles Eric Mowbray, David Anthony Price, Matthew Duncan Selby, Paul Anthony Stupple
  • Publication number: 20090077922
    Abstract: The present invention is a novel removable wallboard system. It includes a plurality of receiver strips [1] which are attached to framing members [8] of a structure to be paneled. Each receiver strip has a receiving channel [4]. Wall panels 7 are placed snugly between the receiver strips [1]. Trim units [2] are elongated strips having insertion strips [10] which are designed to fit into and be retained by receiving channels [4] of the receiver strips [1]. Since the trim units [2] are designed to have a low profile, and they cover the seams between the wall panels [7], there is no need for further finishing or caulking. Therefore, these wall panels [7] may be removed and replaced with minimal effort or cleanup. The system also includes easily installable, removable and replaceable base molding [16], crown molding [19], and chair rail molding [29]. These may be designed to create chase ways [18, 74] allowing hidden routing of electrical, utility cables, pipes and hoses.
    Type: Application
    Filed: September 25, 2008
    Publication date: March 26, 2009
    Inventors: Thomas Pettine, Howard Jones
  • Publication number: 20090036419
    Abstract: The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
    Type: Application
    Filed: June 30, 2008
    Publication date: February 5, 2009
    Applicant: Sunesis Pharmaceuticals, Inc.
    Inventors: Weirong Chen, Jennifer Cossrow, Lloyd Franklin, Bing Guan, John Howard Jones, Gnanasambandam Kumaravel, Benjamin Lane, Adam Littke, Alexey Lugovskoy, Hairuo Peng, Noel Powell, Brian C. Raimundo, Hiroko Tanaka, Jeffrey Vessels, Thomas Wynn, Zhili Xin
  • Publication number: 20090005359
    Abstract: The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.
    Type: Application
    Filed: June 30, 2008
    Publication date: January 1, 2009
    Applicant: Sunesis Pharmaceuticals, Inc
    Inventors: Jennifer Cossrow, Bing Guan, Alexey Ishchenko, John Howard Jones, Gnanasambandam Kumaravel, Alexey Lugovskoy, Hairuo Peng, Noel Powell, Brian C. Raimundo, Hiroko Tanaka, Jeffrey Vessels, Thomas Wynn, Zhili Xin
  • Patent number: 7435728
    Abstract: This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereofs, wherein R1 to R4 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: October 14, 2008
    Assignee: Pfizer Inc
    Inventors: Lyn Howard Jones, Charles Eric Mowbray, David Anthony Price, Matthew Duncan Selby, Paul Anthony Stupple
  • Publication number: 20080214540
    Abstract: Disclosed are substituted indolealkanoic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds and methods of treatment employing the compounds, as well as methods for their synthesis.
    Type: Application
    Filed: December 4, 2007
    Publication date: September 4, 2008
    Inventors: Michael Lee Jones, David Gunn, John Howard Jones, Michael C. Van Zandt
  • Publication number: 20080176919
    Abstract: This invention relates to benzonitrile derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R1 to R3 are defined in the description, to their use in medicine, and to compositions containing them. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof.
    Type: Application
    Filed: December 23, 2005
    Publication date: July 24, 2008
    Inventors: Lyn Howard Jones, Sandra Dora Newman, Nigel Alan Swain
  • Publication number: 20080132549
    Abstract: This invention relates to isophthalonitrile derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R1 to R3 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof.
    Type: Application
    Filed: April 11, 2005
    Publication date: June 5, 2008
    Applicant: Pfizer Inc.
    Inventors: Lyn Howard Jones, Shahid Mohammed, Sandra Newman, Charles Eric Mowbray, Matthew Ducan Selby, Paul Anthony Stupple, Nigel Alan Swain
  • Publication number: 20080127075
    Abstract: A method and system for enforcing version control is provided. An embodiment of the method comprises receiving a command to execute code. Code is retrieved from a code management storage and loaded into a controlled storage. The code may comprise test and program components. The code is executed and the results of the executed code are recorded and logged, and the code is removed from the controlled storage. The system includes an interface for receiving the execute code command and is coupled to the controlled storage. A code loader for loading code into the controlled storage may also be provided.
    Type: Application
    Filed: October 12, 2006
    Publication date: May 29, 2008
    Inventors: Nicholas Howard Jones, Jonathan Paul Kneller, Mark Brian Thomas
  • Patent number: 7346545
    Abstract: The present invention is directed to a method and system for distributing or obtaining products covered by intellectual property over a telecommunications network whereby a consumer may, rather paying for the products, choose to receive such products after viewing and/or interacting with an interposed sponsor's or advertiser's message, wherein the interposed sponsor or advertiser may pay the owner or assignee of the underlying intellectual property associated with the product through an intermediary such as a facilitator.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: March 18, 2008
    Assignee: Ultramercial, Inc.
    Inventor: Dana Howard Jones